Clinica Chimica Acta出版了臨床化學和實驗室醫學領域的原始研究通訊，定義為化學、生物化學、免疫化學、血液學的生化方面、毒理學和分子生物學在體液、細胞或組織中人類疾病研究中的應用，其目標是該雜志將出版新的信息，以更好地了解人類疾病的生物學機制、預防、診斷和患者管理。也歡迎有關應用臨床特征的報告。有關正常代謝過程或正常細胞或體液成分的論文，如動物實驗或臨床研究報告，在其中被認為與人類疾病有明確和直接的關系。還將考慮開發和評估適用于臨床化學和實驗室醫學的新型分析方法，包括護理點測試，以及關于實驗室管理和信息學的主題。除了最初的研究通訊外，該雜志還出版：（1）提供結論性結果或文件方法進展的有限范圍的簡短通訊報告；（2）致編輯的信，對發表在《臨床化學學報》上的論文發表評論-這些應該少于400個字，可能包括1個插圖。R 1表；（3）邀請對醫學生物化學和實驗室醫學的最新中心發展進行評論；（4）涉及有趣或新穎臨床實驗室數據的病例報告；（5）科學學會通訊；（6）會議公告。提交給Clinica Chimica Acta的打字稿以前不應出版，也不應考慮在其他地方出版。必須確認所有指定作者同意提交。涉及人或動物的調查必須注意相關的倫理批準。如果作者對提議論文的范圍、格式或內容有任何疑問，請咨詢編輯委員會的任何成員。

Clinica Chimica Acta publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids, cells or tissues The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are considered in they are clearly and directly relevant to human disease. Development and evaluation of novel analytical methologies where applicable to clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. In addition to original Research Communications the journal publishes: (1) Short Communications-concise reports of limited scope which offer conclusive results or document methodological advances; (2) Letters to the Editor, commenting on papers published in Clinica Chimica Acta - these should be less than 400 words and may include 1 illustration or 1 table; (3) Invited Critical Reviews of recent central developments in medical biochemistry and laboratory medicine; (4) case reports involving interesting or novel clinical laboratory data; (5) Newsletters of Scientific Societies; (6) Meeting announcements. Typescripts submitted to Clinica Chimica Acta should not have been published previously and should not be under consideration for publication elsewhere. The agreement of all named authors to the submission must be affirmed. Relevant ethical approval must be noted for investigations involving human or animal subjects. Authors are invited to consult any member of the Editorial Board, if in doubt about any aspect of scope, format or content of a proposed paper.